MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617082244 A) filed by Ucb Biopharma Srl on July 03, 2026, for Antibodies.
Inventors include Bithell, Rosemary Frances; Bowsher, Leo Alexander; Humphreys, David Paul; Rapecki, Stephen Edward; and Tyson, Kerry Louise.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: The present invention provides in particular antibodies or antigen-binding fragments thereof which are specific for CD45. The antibodies include antibodies that are monospecific for CD45, as well as antibodies that are biparatopic for CD45. The antibodies are typically able to bind both human and cynomolgus monkey CD45. The antibodies of the invention have various uses involving targeting, depleting, and killing cells expressing CD45, particularly for the treatment of cancer or autoimmune diseases which are mediated by CD45 positive cells or prior to the transplant of cells.
Disclaimer: Curated by HT Syndication.
